3. Future of Anti-viral Agents
暂无分享，去创建一个
[1] N. Leung,et al. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. , 2005, Gastroenterology.
[2] P. Marcellin,et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. , 2004, The New England journal of medicine.
[3] B. Beckermann,et al. Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids , 2003, Science.
[4] R. Schinazi,et al. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. , 2001, The Journal of clinical investigation.
[5] M. Omata. Treatment of chronic hepatitis B infection. , 1998, The New England journal of medicine.